Identification of molecular factors mediating therapeutic resistance in diffuse large B-cell lymphoma (DLBCL)
The prognosis for relapsed and refractory diffuse large B-cell lymphoma (DLBCL) is very poor, emphasizing the critical need to identify the underlying molecular mechanisms and targeted treatments. In this study, we delved into the molecular factors driving therapeutic resistance in DLBCL by conducti...
Saved in:
Main Author: | Peng, Chenchen |
---|---|
Other Authors: | Li Yinghui |
Format: | Thesis-Doctor of Philosophy |
Language: | English |
Published: |
Nanyang Technological University
2024
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/174839 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
A multi-institutional analysis of diffuse large B-cell lymphoma (DLBCL) treated with consolidative radiotherapy and the impact of cell-of-origin on outcomes
by: Rajasooriyar, Chrishanthi, et al.
Published: (2023) -
STUDI PENGGUNAAN KEMOTERAPI PADA PASIEN LIMFOMA NON
HODGKIN TIPE DIFFUSE LARGE B CELL LYMPHOMA (DLBCL)
(Penelitian dilakukan di RSUD Dr. Soetomo Surabaya)
by: DIRANI, 051511133064
Published: (2019) -
Plasma Factors for the Differentiation of Hodgkin's Lymphoma and Diffused Large B Cell Lymphoma and for Monitoring Remission.
by: Zeng, Qun, et al.
Published: (2023) -
Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma
by: Liu, Min, et al.
Published: (2024) -
High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma
by: Ong, Shin Yeu, et al.
Published: (2021)